These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 11881351)
21. [Prospects of using immunocorrective treatment with an active thymus factor (taktivin) in dermatology]. Skripkin IuK; Korotkiĭ NG; Udzhukhu VIu; Arion VIa; Eletskiĭ AIu Vestn Dermatol Venerol; 1986; (4):4-7. PubMed ID: 3487189 [No Abstract] [Full Text] [Related]
22. [New pharmacotherapeutic approach to the treatment and prophylaxis of ischemic insult]. Karpenko LN; Kaminskiĭ AA; Lomako VV; Mel'nik UI Klin Khir; 2006 Aug; (8):37-9. PubMed ID: 17115612 [TBL] [Abstract][Full Text] [Related]
23. [Saprotrophic bacteria as a possible means of controlling the immune status of the body through regulation of metabolic reactions]. Piruzian LA; Mikhaĭlovskiĭ EM Fiziol Cheloveka; 2005; 31(1):88-99. PubMed ID: 15835766 [No Abstract] [Full Text] [Related]
24. [Possible use of diucifon in true eczema]. Kubanova AA; Vadil'eva LL; Petrova IV; Leshchenko GM Vestn Dermatol Venerol; 1983 Dec; (12):24-6. PubMed ID: 6369823 [No Abstract] [Full Text] [Related]
26. [The state of the blood clotting system, protein fractions and vascular wall permeability in eczema patients]. Trutiak LN Vestn Dermatol Venerol; 1970 Dec; 44(12):26-9. PubMed ID: 5516661 [No Abstract] [Full Text] [Related]
27. [Pathogenesis and therapy of the so-called microbial eczema]. Meyer-Rohn J Z Hautkr; 1977; 52 Suppl 2():55-8. PubMed ID: 595757 [No Abstract] [Full Text] [Related]
28. Biologic and immunomodulating factors in the treatment of pediatric acquired immunodeficiency syndrome. Ammann AJ Pediatr Infect Dis J; 1990 Dec; 9(12):894-904. PubMed ID: 1703652 [No Abstract] [Full Text] [Related]
29. [The effect of different methods of treatment on the urinary excretion and concentration of vitamin "C" in the blood of microbial eczema patients]. Vanat SV Vrach Delo; 1971 Jan; (1):109-10. PubMed ID: 5576551 [No Abstract] [Full Text] [Related]
30. New immunotherapeutic approaches: the use of cytokines to stimulate the immune system or to control the growth of malignant lymphoid cells. Fridman WH Eur J Cancer Clin Oncol; 1989 Nov; 25(11):1525-8. PubMed ID: 2687003 [No Abstract] [Full Text] [Related]
31. Fusidic acid plus betamethasone in infected or potentially infected eczema. Hjorth N; Schmidt H; Thomsen K Pharmatherapeutica; 1985; 4(2):126-31. PubMed ID: 3903779 [TBL] [Abstract][Full Text] [Related]
32. [Several indices of intermediary metabolism in patients with microbial eczema]. Kalamkarian AA; Egorov NA; Anikina NI Vestn Dermatol Venerol; 1972 Jun; 46(6):16-21. PubMed ID: 5052782 [No Abstract] [Full Text] [Related]
33. Low dose methotrexate therapy is effective in late-onset atopic dermatitis and idiopathic eczema. Zoller L; Ramon M; Bergman R Isr Med Assoc J; 2008 Jun; 10(6):413-4. PubMed ID: 18669134 [TBL] [Abstract][Full Text] [Related]
34. [Comparative analysis of the effect of the treatment with vegetotropic and hormonal complexes on biochemical indicators in patients with eczema]. Goncharov NA; Tseraidis GS; Goncharenko MS; Beliaev GM; Bakhova LK Vestn Dermatol Venerol; 1983 Oct; (10):48-53. PubMed ID: 6559020 [No Abstract] [Full Text] [Related]
35. [The dynamics of the kallikrein-kinin system indices in patients with eczema vera during treatment by the laser photophoresis method with ortofen]. Mandel' ASh; Batychko SI; Korolev VV; Muzyka VI; Smorodin EP; Fedorov SM Vestn Dermatol Venerol; 1990; (9):42-4. PubMed ID: 2284857 [TBL] [Abstract][Full Text] [Related]
37. Comparison of fluticasone propionate cream, 0.05%, and hydrocortisone-17-butyrate cream, 0.1%, in the treatment of eczema. Juhlin L Cutis; 1996 Feb; 57(2 Suppl):51-6. PubMed ID: 8646871 [TBL] [Abstract][Full Text] [Related]